Corrigendum: Treatment of surgical brain injury by immune tolerance induced by peripheral intravenous injection of biotargeting nanoparticles loaded with brain antigens

Front Immunol. 2023 Dec 8:14:1335541. doi: 10.3389/fimmu.2023.1335541. eCollection 2023.

Zhen Tian^#^{1

2}, Lixia Xu^#², Qian Chen^#¹, Ruoyang Feng¹, Hao Lu¹, Huajun Tan¹, Jianming Kang³, Yinsong Wang⁴, Hua Yan^{2

3}

¹ Graduate School of Tianjin Medical University, Tianjin, China.
² Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin, China.
³ Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
⁴ Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), Research Center of Basic Medical Science, School of Pharmacy, Tianjin Medical University, Tianjin, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.00743.].

Keywords: PBAE/PLGA nanoparticles; biotargeting nanoparticles; immune tolerance; myelin basic protein; surgical brain injury.